Tag: syngene shares

This pharma stock made investors nearly 200% wealthier in a year, Goldman Sachs suggests buying more – CNBC TV18

[ad_1] Goldman Sachs’ top pharma stock picks — Syngene and Neuland — traded lower amid an overall downtrend in the stock market on December 13. However, the brokerage continues to recommend buying them. Company Value Change %Change The shares of Neuland Laboratories traded over 3% lower on NSE at 12:30 pm. However, the stock has […]

Back To Top
Translate »